Adela R Cardones (A R Cardones)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Mechanical Ventilation

Chronic Lymphocytic Leukemia

Top Venues

The British journal of dermatology

Clinical and experimental dermatology

Current dermatology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Caitlin L Penny, Krystina Quow, Chandler W Rundle, Rami N Al-Rohil, Adela R Cardones, Meenal K Kheterpal, Amber I Fresco
Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin. The British journal of dermatology 187 (1) (2022)
Morgan E Belina, Timothy A Driscoll, Sarah K Blanchard, Adela R Cardones
Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease. Pediatric dermatology 39 (3) (2022)
Tulsi Patel, Krystina Quow, Adela R Cardones
Management of Infectious Emergencies for the Inpatient Dermatologist. Current dermatology reports (2021)
S K Blanchard, K M Sullivan, J N Hooten, Z E Holcomb, K Rowe Nichols, M A Selim, C L Rao, Russell P Hall, N J Chao, Adela R Cardones
High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. The British journal of dermatology 181 (4) (2019)
Ashwin Agarwal, Russell P Hall, Lionel L Bañez, Adela R Cardones
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis. PloS one 13 (9) (2018)
A L Marano, J M Clarke, M A Morse, A Shah, W Barrow, M A Selim, Russell P Hall, Adela R Cardones
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy. The British journal of dermatology 181 (3) (2018)
Charles J Puza, S A Myers, Adela R Cardones, G M Beasley, P J Mosca
The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients. Clinical and experimental dermatology 44 (3) (2018)
Adela R Cardones, Russell P Hall
Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients? The British journal of dermatology 177 (5) (2018)